Methods
Between December 1990 and December 1999, 1,142 patients with AMI were admitted to the coronary care unit. Eighty-five consecutive patients (71 men, 14 women; mean age [±SD] 59±11 years, range, 34-76) fulfilled the following inclusion criteria and were enrolled: (1) no history of myocardial infarction; (2) typical chest pain for at least 30 min; (3) ST-segment elevation of >0.2 mV in at least 2 contiguous precordial leads; (4) total occlusion (Thrombolysis in Myocardial Infarcton [TIMI] grade 0) 9 of the left anterior descending artery (LAD); (6) successful reperfusion (TIMI grade 3 flow) within 6 h of onset; (7) a patent LAD at 14±4 hospital days; and (8) a normal serum creatine kinase (CK) level on admission, followed by elevation of CK to more than twice the upper limit of normal.
Coronary angiography was performed immediately after admission and a mean of 14 days after infarction. The grade of collateral filling of the LAD was evaluated according to the criteria of Rentrop et al: 10 0 = no visible filling of any collateral channel; 1 = filling of side branches only without visualization of the epicardial segment; 2 = partial filling of the epicardial segment; and 3 = complete filling of the epicardial segment. Good collateral filling was defined as grade 2 or 3, and poor collateral filling as grade 0 or 1. Reperfusion was defined as establishment of TIMI grade 3 coronary flow and was achieved by thrombolysis in 27 patients and by primary or rescue coronary angioplasty in 58 patients. Left ventricular volume was evaluated by the arealength method. Left ventricular ejection fraction (LVEF %) was calculated using end-diastolic volume (LVEDV) and end-systolic volume (LVESV) as (LVEDV-LVESV) ×100 / Japanese Circulation Journal Vol.65, February 2001 LVEDV. Regional wall motion (RWM) in the territory of the LAD was assessed from the left ventriculogram using the centerline method along 100 chords drawn perpendicular to a centerline constructed midway between the end-systolic and end-diastolic contours. Each shortening fraction was normalized to the end-diastolic perimeter of the left ventricle. This normalized chord motion was expressed as standard deviation from the mean wall motion of normal subjects (SD/chord). 11 Routine blood samples for measuring plasma CRP levels were taken on admission. CRP levels were measured by turbidimetric immunoassay with the use of an autoanalyzer (Nihondensi, JEOL, JCA-RX 20, Tokyo, Japan), which is not a highly sensitive method. The normal value of CRP was taken as less than 0.2 mg/dl. None of the patients had other conditions known to modify the plasma CRP level (ie, collagen disease, advanced liver disease, malignant disease, septicemia, arthritis, or other inflammatory or infectious diseases). Blood samples for measurement of serum CK were taken on admission, every 3 h during the first 24 h, every 6 h for the next 2 days, and then daily until discharge. CK was measured by the method based on the International Federation of Clinical and Laboratory Medicine. The normal range of CK in this study was 46-188 mU/ml in males and 30-124 mU/ml in females.
Unstable angina was defined as crescendo angina (more severe, prolonged, or frequent) superimposed on a preexisting pattern of relatively stable exertion-related angina pectoris, as angina pectoris of new onset (usually within 1 month), or as angina pectoris at rest as well as on minimal exertion. The type of unstable angina was also categorized according to the Braunwald classification: 12 new onset, severe, or accelerated angina without pain at rest was classified as Class I; angina at rest without pain for 48 h before the onset of AMI was classified as Class II; and angina at rest within 48 h before the onset of AMI was classified as Class III.
Electrocardiograms were recorded immediately after admission. The isoelectric line was defined as the level of the preceding TP segment. ST-segment elevation was measured at the J point. The sum of ST-segment elevation was calculated by summing the magnitude of ST-segment elevation in leads V1-6 and the sum of R waves was calculated by summing the magnitude of R waves in the same leads. In addition, ECGs were scored by the 32-point QRS scoring system. 13 
Statistical Analysis
Variables are expressed as mean ± standard deviation (SD). Variables were compared with the use of a commer- 
Results
Patients were classified into 2 groups: those with low levels (<0.3 mg/dl) of CRP (0.12±0.04 mg/dl, Group L; n=67) and those with high levels (≥0.3 mg/dl) of CRP (0.81±0.56 mg/dl, Group H; n=18). The clinical characteristics of the 2 groups are summarized in Table 1 . There were no differences between the groups other than a history of preinfarction angina, which was significantly higher in Group H patients, especially unstable angina. ΣST in leads V1-6 and QRS score were lower and ΣR in leads V1-6 on admission ECG was higher in Group H than in Group L. The frequency of ST re-elevation immediately after reperfusion was slightly higher in Group L (Table 2) . Peak CK was lower, and LVEF and SD/chord at the LAD lesion at a mean of 14 days after admission were better in Group H. There was no difference in LVEDV index (LVEDVI) between the 2 groups, but the LVESV index (LVESVI) was slightly lower in Group H (Table 3 ). Multivariate analysis showed that both CRP on admission and preinfarction angina were independently associated with better RWM (SD/chord >-2.0) ( Table 4) .
Discussion
The clinical implications of CRP in coronary heart disease are attracting considerable attention. [1] [2] [3] [4] [5] [6] [7] 14, 17 Several studies have demonstrated that higher CRP levels in patients with unstable angina indicate an increased risk of subsequent coronary events. [1] [2] [3] Because CRP is associated with inflammation of coronary vessels, 15 it is reasonable to suggest that high levels are associated with an adverse outcome as a result of the coronary instability. [1] [2] [3] [5] [6] [7] 16, 17 Moreover, CRP at least partially reflects the extent of myocardial necrosis and can be used to predict in-hospital and long-term outcome in patients with AMI. [4] [5] [6] However, these findings apply only CRP concentrations several hours to days after the onset of AMI and the clinical implications of the elevation of CRP immediately after the onset of AMI, before myocardial necrosis, remains to be defined.
We hypothesized that the elevation of CRP immediately after the onset of AMI may protect the myocardium in patients with AMI because increased CRP concentrations are frequently observed in patients with preinfarction unstable angina, which acts as ischemic preconditioning. 18, 19 To test this hypothesis, we only enrolled patients who met strict entry criteria: a first anterior AMI; the culprit lesion involving the proximal LAD with total occlusion; successful reperfusion, confirmed by angiography, within 6 h of onset; no CK elevation on admission; and no ischemic events during hospitalization. Our study showed that immediately after the onset of AMI, patients with elevated CRP had less myocardial damage, a smaller infarct size, and better global and regional left ventricular function than those without elevated CRP. These findings appear to be consistent with those of a recent report by Liuzzo et al 16 who found that peak CK levels did not differ significantly between patients with preceding angina who had higher CRP levels and those with unheralded AMI who had lower CRP levels on entry (peak CK level: 1654±967 vs 1932±1496 IU/L). The lack of difference in the CK levels in that study may relate to patient entry criteria: the infarct site was inconsistent; reperfusion was not immediately confirmed by angiography and there was a higher proportion of patients with anterior AMI (56% vs 30%) in the group with the higher CRP level. Interestingly, multivariate analysis revealed that both CRP and preinfarction angina within 48 h of the onset of AMI were independent factors for better RWM on predischarge left ventriculography. Two mechanisms may account for the myocardial protective effect associated with the elevation of CRP. First, silent myocardial ischemia, which is frequently associated with unstable angina, 20 and in which CRP levels may increase greatly, may exert an ischemic preconditioning effect on the myocardium. Second, inflammation induces expression of angiogenic growth factors associated with reduced infarct size, 21 and endogenous production of NO protects the myocardium from ischemia reperfusion injury. 22 Therefore, the clinical situation in which CRP levels are already elevated immediately after the onset of AMI may protect the ischemic myocardium. Because AMI with elevated CRP levels immediately after the onset may have less myocardial damage and a more fragile culprit lesion, 7 it may be best managed by early implementation of a reliable reperfusion strategy, such as stent replacement or treatment with abciximab. 23, 24 
Conclusions
The clinical situation of elevated CRP immediately after onset is associated with less myocardial damage and better left ventricular function in reperfused anterior AMI.
